LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 3 | B08 | 72 | hr | 1401 | 1448 | 4223 | 0.3429 | 0.0165 |
| SK-BR-3 | HG-5-88-01 | 3.33 | uM | LJP6 | 1 | A20 | 72 | hr | 1401 | 3650 | 4223 | 0.8643 | 0.7969 |
| SK-BR-3 | HG-5-88-01 | 3.33 | uM | LJP6 | 2 | A20 | 72 | hr | 1401 | 3691 | 4223 | 0.8740 | 0.8114 |
| SK-BR-3 | HG-5-88-01 | 3.33 | uM | LJP6 | 3 | A20 | 72 | hr | 1401 | 3549 | 4223 | 0.8404 | 0.7611 |
| SK-BR-3 | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 1401 | 4458 | 4223 | 1.0556 | 1.0833 |
| SK-BR-3 | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 1401 | 4431 | 4223 | 1.0492 | 1.0737 |
| SK-BR-3 | Imatinib | 3.33 | uM | LJP6 | 3 | N14 | 72 | hr | 1401 | 4489 | 4223 | 1.0630 | 1.0942 |
| SK-BR-3 | JNK-9L | 3.33 | uM | LJP6 | 1 | K20 | 72 | hr | 1401 | 1064 | 4223 | 0.2520 | -0.1196 |
| SK-BR-3 | JNK-9L | 3.33 | uM | LJP6 | 2 | K20 | 72 | hr | 1401 | 1230 | 4223 | 0.2913 | -0.0608 |
| SK-BR-3 | JNK-9L | 3.33 | uM | LJP6 | 3 | K20 | 72 | hr | 1401 | 1196 | 4223 | 0.2832 | -0.0728 |
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 1 | B20 | 72 | hr | 1401 | 2168 | 4223 | 0.5134 | 0.2717 |
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 1401 | 1987 | 4223 | 0.4705 | 0.2075 |
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 1401 | 2240 | 4223 | 0.5304 | 0.2972 |
| SK-BR-3 | Lapatinib | 3.33 | uM | LJP6 | 1 | M20 | 72 | hr | 1401 | 1560 | 4223 | 0.3694 | 0.0562 |
| SK-BR-3 | Lapatinib | 3.33 | uM | LJP6 | 2 | M20 | 72 | hr | 1401 | 1765 | 4223 | 0.4179 | 0.1288 |
| SK-BR-3 | Lapatinib | 3.33 | uM | LJP6 | 3 | M20 | 72 | hr | 1401 | 1682 | 4223 | 0.3983 | 0.0994 |
| SK-BR-3 | LDN-193189 | 3.33 | uM | LJP5 | 1 | G02 | 72 | hr | 1401 | 418 | 4223 | 0.0990 | -0.3486 |
| SK-BR-3 | LDN-193189 | 3.33 | uM | LJP5 | 2 | G02 | 72 | hr | 1401 | 870 | 4223 | 0.2060 | -0.1884 |
| SK-BR-3 | LDN-193189 | 3.33 | uM | LJP5 | 3 | G02 | 72 | hr | 1401 | 1791 | 4223 | 0.4241 | 0.1380 |
| SK-BR-3 | Linifanib | 3.33 | uM | LJP6 | 1 | J08 | 72 | hr | 1401 | 4411 | 4223 | 1.0445 | 1.0666 |
| SK-BR-3 | Linifanib | 3.33 | uM | LJP6 | 2 | J08 | 72 | hr | 1401 | 4493 | 4223 | 1.0639 | 1.0957 |
| SK-BR-3 | Linifanib | 3.33 | uM | LJP6 | 3 | J08 | 72 | hr | 1401 | 4501 | 4223 | 1.0658 | 1.0985 |
| SK-BR-3 | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 1401 | 3025 | 4223 | 0.7163 | 0.5754 |
| SK-BR-3 | Linsitinib | 3.33 | uM | LJP5 | 2 | O20 | 72 | hr | 1401 | 3414 | 4223 | 0.8084 | 0.7133 |
| SK-BR-3 | Linsitinib | 3.33 | uM | LJP5 | 3 | O20 | 72 | hr | 1401 | 3892 | 4223 | 0.9216 | 0.8827 |